SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF 1-(AMINOMETHYL)-3,4-DIHYDRO-5-HYDROXY-1H-2-BENZOPYRANS AS DOPAMINE-D1 SELECTIVE LIGANDS

被引:21
作者
MICHAELIDES, MR
SCHOENLEBER, R
THOMAS, S
YAMAMOTO, DM
BRITTON, DR
MACKENZIE, R
KEBABIAN, JW
机构
[1] Neuroscience Research, Pharmaceutical Discovery, Abbott Laboratories, Abbott Park
关键词
D O I
10.1021/jm00114a002
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 3-substituted 1-(aminomethyl)-3,4-dihydro-5-hydroxy-1H-2-benzopyrans were prepared as potential D1 selective antagonists. The compounds were evaluated for their affinity and selectivity for the D1 receptor as well as for their functional antagonism of D1-mediated pharmacological events. The compounds show potent D1 antagonist properties in vitro. The optimum nitrogen substitution was found to be the primary amine and the observed order of potency for substitution at the 6-position is OH > Br > H > OMe. Two representative compounds, the 6-methyl and 6-bromo analogues, were also evaluated in vivo for dopaminergic activity. Interestingly, both compounds behave as potent in vivo agonists.
引用
收藏
页码:2946 / 2953
页数:8
相关论文
共 45 条
[1]   THIENOPYRIDINE DERIVATIVES IDENTIFIED AS THE 1ST SELECTIVE, FULL EFFICACY, DOPAMINE D1 RECEPTOR AGONISTS [J].
ANDERSEN, PH ;
NIELSEN, EB ;
SCHEELKRUGER, J ;
JANSEN, JA ;
HOHLWEG, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 137 (2-3) :291-292
[3]   SYNTHESIS AND RECEPTOR AFFINITIES OF SOME CONFORMATIONALLY RESTRICTED ANALOGS OF THE DOPAMINE D1 SELECTIVE LIGAND (5R)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL [J].
BERGER, JG ;
CHANG, WK ;
CLADER, JW ;
HOU, D ;
CHIPKIN, RE ;
MCPHAIL, AT .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (08) :1913-1921
[4]   TRANS-10,11-DIHYDROXY-5,6,6A,7,8,12B-HEXAHYDROBENZO[A]PHENANTHRIDINE - A HIGHLY POTENT SELECTIVE DOPAMINE-D1 FULL AGONIST [J].
BREWSTER, WK ;
NICHOLS, DE ;
RIGGS, RM ;
MOTTOLA, DM ;
LOVENBERG, TW ;
LEWIS, MH ;
MAILMAN, RB .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (06) :1756-1764
[5]   CLONING AND EXPRESSION OF A RAT D2 DOPAMINE RECEPTOR CDNA [J].
BUNZOW, JR ;
VANTOL, HHM ;
GRANDY, DK ;
ALBERT, P ;
SALON, J ;
CHRISTIE, MJ ;
MACHIDA, CA ;
NEVE, KA ;
CIVELLI, O .
NATURE, 1988, 336 (6201) :783-787
[6]  
CALNE DB, 1983, ACS SYM SER, V224, P147
[7]   ASSESSMENT OF A POTENTIAL DOPAMINERGIC PRODRUG MOIETY IN SEVERAL RING-SYSTEMS [J].
CANNON, JG ;
FURLANO, DC ;
DUSHIN, RG ;
CHANG, YA ;
BAIRD, SR ;
SOLIMAN, LN ;
FLYNN, JR ;
LONG, JP ;
BHATNAGAR, RK .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (10) :2016-2020
[8]   INTRODUCTION OF A PUTATIVE DOPAMINERGIC PRODRUG MOIETY INTO A 6,7-SUBSTITUTION PATTERN CHARACTERISTIC OF CERTAIN 2-AMINOTETRALIN DOPAMINERGIC AGONISTS [J].
CANNON, JG ;
TRUE, CD ;
LONG, JP ;
BHATNAGAR, RK ;
LEONARD, P ;
FLYNN, JR .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (09) :2210-2214
[9]   POSSIBLE BIOLOGICALLY-ACTIVE METABOLITES OF 5-HYDROXY-6-METHYL-2-DI-NORMAL-PROPYLAMINOTETRALIN [J].
CANNON, JG ;
FURLANO, DC ;
KOBLE, DL ;
KOONS, JC ;
LONG, JP .
LIFE SCIENCES, 1984, 34 (17) :1679-1682
[10]  
CHARIFSON PS, 1988, J MED CHEM, V321, P1941